Opthea (ASX:OPT) Days Payable : 30,396.94 (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Opthea Days Payable?

Opthea's average Accounts Payable for the six months ended in Dec. 2023 was A$36.98 Mil. Opthea's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.22 Mil. Hence, Opthea's Days Payable for the six months ended in Dec. 2023 was 30,396.94.

The historical rank and industry rank for Opthea's Days Payable or its related term are showing as below:

ASX:OPT' s Days Payable Range Over the Past 10 Years
Min: 2939.84 Med: 8566.38 Max: 31631.61
Current: 30349.19

During the past 13 years, Opthea's highest Days Payable was 31631.61. The lowest was 2939.84. And the median was 8566.38.

ASX:OPT's Days Payable is ranked better than
97.51% of 722 companies
in the Biotechnology industry
Industry Median: 148.53 vs ASX:OPT: 30349.19

Opthea's Days Payable increased from Dec. 2022 (21,930.17) to Dec. 2023 (30,396.94). It may suggest that Opthea delayed paying its suppliers.

Opthea Days Payable Historical Data

The historical data trend for Opthea's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opthea Days Payable Chart

Opthea Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

8,566.38

5,319.34

2,939.84

15,451.14

31,631.61

Opthea Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															25,939.57	14,436.16	21,930.17	28,563.42	30,396.94

Competitive Comparison of Opthea's Days Payable

For the Biotechnology subindustry, Opthea's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opthea's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Opthea's Days Payable distribution charts can be found below:

* The bar in red indicates where Opthea's Days Payable falls into.

Opthea Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Opthea's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (16.225	+	26.586)	/	2 )	/	0.247	*	365
=	21.4055					/	0.247	*	365
=	31,631.61

Opthea's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (26.586	+	47.366)	/	2 )	/	0.222	*	365 / 2
=	36.976					/	0.222	*	365 / 2
=	30,396.94

Opthea Days Payable Related Terms

Thank you for viewing the detailed overview of Opthea's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Opthea (ASX:OPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (ASX:OPT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

OPT:USA UKJ:Germany

Address

650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141

Website

https://www.opthea.com

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.